List of Tables
Table 1. Global Oral Hypoglycemic Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oral Hypoglycemic Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oral Hypoglycemic Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oral Hypoglycemic Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Oral Hypoglycemic Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oral Hypoglycemic Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oral Hypoglycemic Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oral Hypoglycemic Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oral Hypoglycemic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Hypoglycemic Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Hypoglycemic Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Oral Hypoglycemic Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Hypoglycemic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Hypoglycemic Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Hypoglycemic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oral Hypoglycemic Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Oral Hypoglycemic Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Oral Hypoglycemic Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Oral Hypoglycemic Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Oral Hypoglycemic Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oral Hypoglycemic Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Oral Hypoglycemic Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oral Hypoglycemic Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Oral Hypoglycemic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oral Hypoglycemic Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Oral Hypoglycemic Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Oral Hypoglycemic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oral Hypoglycemic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oral Hypoglycemic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oral Hypoglycemic Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Oral Hypoglycemic Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Oral Hypoglycemic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oral Hypoglycemic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oral Hypoglycemic Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oral Hypoglycemic Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Oral Hypoglycemic Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Oral Hypoglycemic Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oral Hypoglycemic Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oral Hypoglycemic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oral Hypoglycemic Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Oral Hypoglycemic Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Oral Hypoglycemic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral Hypoglycemic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oral Hypoglycemic Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Oral Hypoglycemic Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oral Hypoglycemic Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Oral Hypoglycemic Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Oral Hypoglycemic Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Oral Hypoglycemic Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Oral Hypoglycemic Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oral Hypoglycemic Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oral Hypoglycemic Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Oral Hypoglycemic Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Oral Hypoglycemic Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Oral Hypoglycemic Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Oral Hypoglycemic Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Oral Hypoglycemic Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Oral Hypoglycemic Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Oral Hypoglycemic Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Oral Hypoglycemic Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oral Hypoglycemic Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oral Hypoglycemic Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Oral Hypoglycemic Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Oral Hypoglycemic Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Oral Hypoglycemic Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Oral Hypoglycemic Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. AstraZeneca Oral Hypoglycemic Drugs Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Johnson & Johnson Oral Hypoglycemic Drugs Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. GlaxoSmithKline Company Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. GlaxoSmithKline Oral Hypoglycemic Drugs Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. Merck & Co Company Information
Table 91. Merck & Co Description and Business Overview
Table 92. Merck & Co Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Merck & Co Oral Hypoglycemic Drugs Product
Table 94. Merck & Co Recent Developments/Updates
Table 95. Eli Lilly Company Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Eli Lilly Oral Hypoglycemic Drugs Product
Table 99. Eli Lilly Recent Developments/Updates
Table 100. Sanofi Company Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sanofi Oral Hypoglycemic Drugs Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Takeda Pharmaceuticals Company Information
Table 106. Takeda Pharmaceuticals Description and Business Overview
Table 107. Takeda Pharmaceuticals Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Takeda Pharmaceuticals Oral Hypoglycemic Drugs Product
Table 109. Takeda Pharmaceuticals Recent Developments/Updates
Table 110. Novo Nordisk Company Information
Table 111. Novo Nordisk Description and Business Overview
Table 112. Novo Nordisk Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Novo Nordisk Oral Hypoglycemic Drugs Product
Table 114. Novo Nordisk Recent Developments/Updates
Table 115. Servier Laboratories Company Information
Table 116. Servier Laboratories Description and Business Overview
Table 117. Servier Laboratories Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Servier Laboratories Oral Hypoglycemic Drugs Product
Table 119. Servier Laboratories Recent Developments/Updates
Table 120. Boehringer Ingelheim Company Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Boehringer Ingelheim Oral Hypoglycemic Drugs Product
Table 124. Boehringer Ingelheim Recent Developments/Updates
Table 125. Bristol-Myers Squibb Company Information
Table 126. Bristol-Myers Squibb Description and Business Overview
Table 127. Bristol-Myers Squibb Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Bristol-Myers Squibb Oral Hypoglycemic Drugs Product
Table 129. Bristol-Myers Squibb Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Oral Hypoglycemic Drugs Distributors List
Table 133. Oral Hypoglycemic Drugs Customers List
Table 134. Oral Hypoglycemic Drugs Market Trends
Table 135. Oral Hypoglycemic Drugs Market Drivers
Table 136. Oral Hypoglycemic Drugs Market Challenges
Table 137. Oral Hypoglycemic Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Hypoglycemic Drugs
Figure 2. Global Oral Hypoglycemic Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral Hypoglycemic Drugs Market Share by Type: 2024 & 2031
Figure 4. Sulfonylureas (SU) Product Picture
Figure 5. Double Guanidine Product Picture
Figure 6. Glucosidase Inhibitor Product Picture
Figure 7. Insulin Synergist Product Picture
Figure 8. Global Oral Hypoglycemic Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Oral Hypoglycemic Drugs Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Oral Hypoglycemic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oral Hypoglycemic Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Oral Hypoglycemic Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Oral Hypoglycemic Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Oral Hypoglycemic Drugs Report Years Considered
Figure 18. Oral Hypoglycemic Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Oral Hypoglycemic Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Oral Hypoglycemic Drugs Players: Market Share by Revenue in Oral Hypoglycemic Drugs in 2024
Figure 21. Oral Hypoglycemic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Oral Hypoglycemic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Oral Hypoglycemic Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Oral Hypoglycemic Drugs Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Oral Hypoglycemic Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Oral Hypoglycemic Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Oral Hypoglycemic Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Oral Hypoglycemic Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Oral Hypoglycemic Drugs Sales Market Share by Country (2020-2031)
Figure 47. Latin America Oral Hypoglycemic Drugs Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Oral Hypoglycemic Drugs Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Oral Hypoglycemic Drugs Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Oral Hypoglycemic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Oral Hypoglycemic Drugs by Type (2020-2031)
Figure 57. Global Revenue Market Share of Oral Hypoglycemic Drugs by Type (2020-2031)
Figure 58. Global Oral Hypoglycemic Drugs Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Oral Hypoglycemic Drugs by Application (2020-2031)
Figure 60. Global Revenue Market Share of Oral Hypoglycemic Drugs by Application (2020-2031)
Figure 61. Global Oral Hypoglycemic Drugs Price (US$/Unit) by Application (2020-2031)
Figure 62. Oral Hypoglycemic Drugs Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
